Previous Article | Next Article 
Mol Cell Biol. 1981 June; 1(6): 512-521
Isolation and characterization of dexamethasone-resistant mutants from human lymphoid cell line CEM-C7.
J M Harmon and
E B Thompson
Laboratory of Biochemistry, National Cancer Institute, Bethesda, Maryland 20205.
ABSTRACT
Fifty-four independent dexamethasone-resistant clones were isolated from the clonal, glucocorticoid-sensitive human leukemic T-cell line CEM-C7. Resistance to 1 microM dexamethasone was acquired spontaneously at a rate of 2.6 X 10(-5) per cell per generation as determined by fluctuation analysis. After mutagenesis with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), the phenotypic expression time for dexamethasone resistance was determined to be 3 days. Spontaneous acquisition of resistance to 0.1 mM 6-thioguanine appeared to occur at a much slower rate, 1.6 X 10(-6) per cell per generation. However, the expression time after MNNG mutagenesis for this resistant phenotype was greater than 11 days, suggesting that the different rates of acquisition for the two phenotypes measured by fluctuation analysis were the results of the disparate expression times. The mutagens ICR 191 and MNNG were effective in increasing the dexamethasone-resistant fraction of cells in mutagenized cultures; ICR 191 produced a 35.6-fold increase, and MNNG produced an 8.5-fold increase. All the spontaneous dexamethasone-resistant clones contained glucocorticoid receptors, usually less than half of the amount found in the parental clone. They are therefore strikingly different from dexamethasone-resistant clones derived from the mouse cell lines S49 and W7. Dexamethasone-resistant clones isolated after mutagenesis of CEM-C7 contained, on the average, lower concentrations of receptor than did those isolated spontaneously, and one clone contained no detectable receptor. These results are consistent with a mutational origin for dexamethasone resistance in these human cells at a haploid or functionally hemizygous locus. They also suggest that this is a useful system for mutation assay.
Mol Cell Biol. 1981 June; 1(6): 512-521
This article has been cited by other articles:
-
Miller, A. L., Webb, M. S., Copik, A. J., Wang, Y., Johnson, B. H., Kumar, R., Thompson, E. B.
(2005). p38 Mitogen-Activated Protein Kinase (MAPK) Is a Key Mediator in Glucocorticoid-Induced Apoptosis of Lymphoid Cells: Correlation between p38 MAPK Activation and Site-Specific Phosphorylation of the Human Glucocorticoid Receptor at Serine 211. Mol. Endocrinol.
19: 1569-1583
[Abstract]
[Full Text]
-
Herr, I., Ucur, E., Herzer, K., Okouoyo, S., Ridder, R., Krammer, P. H., von Knebel Doeberitz, M., Debatin, K.-M.
(2003). Glucocorticoid Cotreatment Induces Apoptosis Resistance toward Cancer Therapy in Carcinomas. Cancer Res.
63: 3112-3120
[Abstract]
[Full Text]
-
Thompson, E. B., Johnson, B. H.
(2003). Regulation of a Distinctive Set of Genes in Glucocorticoid-evoked Apoptosis in CEM Human Lymphoid Cells. Recent Prog Horm Res
58: 175-197
[Abstract]
[Full Text]
-
Bernardi, R. J., Trump, D. L., Yu, W.-D., McGuire, T. F., Hershberger, P. A., Johnson, C. S.
(2001). Combination of 1{alpha},25-Dihydroxyvitamin D3 with Dexamethasone Enhances Cell Cycle Arrest and Apoptosis: Role of Nuclear Receptor Cross-Talk and Erk/Akt Signaling. Clin. Cancer Res.
7: 4164-4173
[Abstract]
[Full Text]
-
Breslin, M. B., Geng, C.-D., Vedeckis, W. V.
(2001). Multiple Promoters Exist in the Human GR Gene, One of Which Is Activated by Glucocorticoids. Mol. Endocrinol.
15: 1381-1395
[Abstract]
[Full Text]
-
Hillmann, A. G., Ramdas, J., Multanen, K., Norman, M. R., Harmon, J. M.
(2000). Glucocorticoid Receptor Gene Mutations in Leukemic Cells Acquired in Vitro and in Vivo. Cancer Res.
60: 2056-2062
[Abstract]
[Full Text]
-
Cifone, M. G., Migliorati, G., Parroni, R., Marchetti, C., Millimaggi, D., Santoni, A., Riccardi, C.
(1999). Dexamethasone-Induced Thymocyte Apoptosis: Apoptotic Signal Involves the Sequential Activation of Phosphoinositide-Specific Phospholipase C, Acidic Sphingomyelinase, and Caspases. Blood
93: 2282-2296
[Abstract]
[Full Text]
-
Ramdas, J., Liu, W., Harmon, J. M.
(1999). Glucocorticoid-induced Cell Death Requires Autoinduction of Glucocorticoid Receptor Expression in Human Leukemic T Cells. Cancer Res.
59: 1378-1385
[Abstract]
[Full Text]
-
Ramdas, J., Harmon, J. M.
(1998). Glucocorticoid-Induced Apoptosis and Regulation of NF-{kappa}B Activity in Human Leukemic T Cells. Endocrinology
139: 3813-3821
[Abstract]
[Full Text]
-
Chen, H., Srinivasan, G., Thompson, E. B.
(1997). Protein-Protein Interactions Are Implied in Glucocorticoid Receptor Mutant 465*-mediated Cell Death. J. Biol. Chem.
272: 25873-25880
[Abstract]
[Full Text]
-
Hughes, M., Malloy, P., Kieback, D., Kesterson, R., Pike, J., Feldman, D, O'Malley, B.
(1988). Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets. Science
242: 1702-1705
[Abstract]
-
Webster, J. C., Oakley, R. H., Jewell, C. M., Cidlowski, J. A.
(2001). Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: A mechanism for the generation of glucocorticoid resistance. Proc. Natl. Acad. Sci. USA
98: 6865-6870
[Abstract]
[Full Text]
Copyright © 1981 by the American Society for Microbiology. All rights reserved.